(Press-News.org) BOSTON—People who are married when diagnosed with cancer live longer than those who are not, report researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital. Married patients also tended to have cancers diagnosed at an earlier stage – when it is often more successfully treated – and to receive more appropriate treatment.
The study's findings will be published online by the Journal of Clinical Oncology on Sept. 23.
"Our data suggests that marriage can have a significant health impact for patients with cancer, and this was consistent among every cancer that we reviewed," said Ayal Aizer, MD MHS, chief resident of the Harvard Radiation Oncology Program and the paper's first author. "We suspect that social support from spouses is what's driving the striking improvement in survival. Spouses often accompany patients on their visits and make sure they understand the recommendations and complete all their treatments."
Utilizing the National Cancer Institute's Surveillance, Epidemiology and End Results Program, the researchers conducted a retrospective analysis of 734,889 people who were diagnosed with cancer between 2004 and 2008. They focused on the 10 leading causes of cancer deaths in the United States: lung, colorectal, breast, pancreatic, prostate, liver/bile duct, non-Hodgkin lymphoma, head and neck, ovarian, and esophageal cancer. They also adjusted the data to account for a number of demographic factors, including age, sex, race, residence type, education and median household income, that could have an effect on the health outcome.
Their analysis found that in comparison with married patients, unmarried cancer patients, including those who were widowed, were 17 percent more likely to have metastatic cancer (cancer that spread beyond its original site) and were 53 percent less likely to receive the appropriate therapy.
"We don't just see our study as an affirmation of marriage, but rather it should send a message to anyone who has a friend or a loved one with cancer: by being there for that person and helping them navigate their appointments and make it through all their treatments, you can make a real difference to that person's outcome," said the study's senior author Paul Nguyen, MD, a radiation oncologist at Dana-Farber and Brigham and Women's. "As oncologists, we need to be aware of our patients' available social supports and encourage them to seek and accept support from friends and family during this potentially difficult time."
INFORMATION:
In addition to Aizer and Nguyen, the study's other authors are Ming-Hui Chen, MD, of the University of Connecticut, Storrs; Mallika Mendu, MD, and Sophia Koo, MD, of Brigham and Women's; Ellen McCarthy, PhD, Powell Graham and Tyler Wilhite, of Harvard Medical School; Toni Choueiri, MD, and Neil Martin, MD, Dana-Farber and Brigham and Women's; Jim Hu MD MPH, of the University of California, Los Angeles; and Karen Hoffman MD MPH MHSc, of MD Anderson Cancer Center, Houston.
The study was funded in part by Heritage Medical Research Institute/Prostate Cancer Foundation Young Investigator Award, JCRT Foundation Grant, Fitz's Cancer Warriors, David and Cynthia Chapin, and a grant from an anonymous family foundation.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Facebook and on Twitter.
Marriage associated with better cancer outcomes, study finds
2013-09-24
ELSE PRESS RELEASES FROM THIS DATE:
Global warming is likely to increase severe thunderstorm conditions in US, Stanford research finds
2013-09-24
In 2012, 11 weather disasters in the United States crossed the billion-dollar threshold in economic losses. Seven of those events were related to severe thunderstorms.
New climate analyses led by Stanford scientists indicate that global warming is likely to cause a robust increase in the conditions that produce these types of storms across much of the country over the next century.
Severe thunderstorms are one of the primary causes of catastrophic losses in the United States and often exhibit the conditions that generate heavy rainfall, damaging winds, hail and tornadoes.
Sparse ...
Siberian hamsters show what helps make seasonal clocks tick
2013-09-24
Many animals, including humans, have internal clocks and calendars to help them regulate behavior, physiological functions and biological processes. Although scientists have extensively studied the timekeeping mechanisms that inform daily functions (circadian rhythms), they know very little about the timekeeping mechanisms that inform seasonal functions.
New research to be published this week in the online early edition of the Proceedings of the National Academy of Sciences shows, for the first time, that this measurement of seasonal time has an epigenetic component. ...
Large European study suggests men with type 1 diabetes are better at blood sugar control than women
2013-09-24
Men with type 1 diabetes appear to be better at blood sugar control than women, but there is no significant difference in blood sugar control between boys and girls. These are the findings of new research presented at this week's annual meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. The research is by Professor Sarah Wild, University of Edinburgh, UK, and colleagues from the International quality of care for type 1 diabetes group.
Since there are limited data showing differences in blood sugar control in type 1 diabetes between ...
Non-precious metal catalysts outperforming Pt-based one by UNIST research team
2013-09-24
Researchers from Ulsan National Institute of Science and Technology (UNIST), Korea Institute of Energy Research (KIER), and Brookhaven National Laboratory, have discovered a new family of non-precious metal catalysts. These catalysts exhibit better performance than platinum in oxygen-reduction reaction (ORR) only with 10 % of the production cost of a platinum catalyst.
The finding, described in Nature's Scientific Reports (published online on Step. 23, 2013), provides an important step towards circumventing the biggest obstacle to widespread- commercialization of fuel ...
Managed care reduces hospitalizations in nursing home residents with advanced dementia
2013-09-24
BOSTON – Nursing home residents with advanced dementia commonly experience burdensome, costly interventions that do not improve their quality of life or extend their survival. Now a new study suggests that providing intensive primary care services may result in less burdensome and less costly care for these terminally ill residents.
Led by researchers at the Harvard Medical School-affiliated Institute for Aging Research at Hebrew SeniorLife, New York University School of Medicine, Harvard Medical School, and Beth Israel Deaconess Medical Center, the study appears in ...
'Reassuring' findings released in national study of influenza vaccine safety in pregnancy
2013-09-24
SAN DIEGO, CA – Researchers from Boston University's Slone Epidemiology Center and UC San Diego, in collaboration with the American Academy of Allergy Asthma and Immunology (AAAAI), have found 'reassuring' evidence of the H1N1 influenza vaccine's safety during pregnancy. The national study, which was launched shortly after the pandemic H1N1 influenza outbreak of 2009 and funded by the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA), will be summarized in two companion papers published online this month in the journal, ...
No detectable association between frequency of marijuana use and health or healthcare utilization
2013-09-24
(Boston)--Researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) have found frequency of marijuana use was not significantly associated with health services utilization or health status. These findings currently appear online in the Journal of General Internal Medicine.
As marijuana's legal status changes across the US, its impact on health has become of great interest. Marijuana is the most commonly used illicit drug, yet its impact on health and healthcare utilization has not been studied extensively.
The researchers studied ...
Pesticide regulation in California is flawed, UCLA report says
2013-09-24
Approximately 30 million pounds of fumigant pesticides are used each year on soil that yields valuable California crops— strawberries, tomatoes, peppers and the like — in an attempt to control pests. Responsibility for the safety of pesticides must be evaluated and approved by the California Department of Pesticide Regulation in a process known as registration.
A new report issued by UCLA's Sustainable Technology and Policy Program, a joint program of the Fielding School of Public Health and the School of Law, shows that in at least one case, the system failed by approving ...
Protecting specific area of the brain during radiation therapy substantially reduces memory loss
2013-09-24
ATLANTA – Sept. 23, 2013. Protecting the stem cells that reside in and around the hippocampus – a C-shaped area in the temporal lobe on both sides of the brain associated with the ability to form and store memories – substantially reduces the rate of cancer patients' memory loss during whole-brain radiotherapy without a significant risk of recurrence in that area of the brain, a new study shows. Results of the Phase II clinical trial of patients with brain metastases are being presented today at the American Society for Radiation Oncology (ASTRO) annual meeting.
"Memory ...
Johns Hopkins researchers erase human brain tumor cells in mice
2013-09-24
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of — and ultimately left no detectable trace of — brain tumor cells taken from adult human patients.
The scientists targeted a mutation in the IDH1 gene first identified in human brain tumors called gliomas by a team of Johns Hopkins cancer researchers in 2008. This mutation was found in 70 to 80 percent of lower-grade and progressive forms of the brain cancer. The change occurs within a single spot along a string of thousands of genetic ...